The Enterprise Value as of November 2024 (TTM) for Vaccitech plc (VACC) is 45.13M

According to Vaccitech plc’s latest financial reports and current stock price. The company's current Enterprise Value is 45.13M. This represents a change of -159.38% compared to the average of -75993551.66 of the last 4 quarters.

Vaccitech plc (VACC) Historical Enterprise Value (quarterly & annually)

How has VACC Enterprise Value performed in the past?

The mean historical Enterprise Value of Vaccitech plc over the last ten years is 22.00M. The current 45.13M Enterprise Value has changed 20.41% with respect to the historical average. Over the past ten years (40 quarters), VACC's Enterprise Value was at its highest in in the March 2021 quarter at 326.01M. The Enterprise Value was at its lowest in in the December 2022 quarter at -97836813.95.

Vaccitech plc (VACC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vaccitech plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vaccitech plc (VACC) Average Enterprise Value

How has VACC Enterprise Value performed in the past?

The current Enterprise Value of Vaccitech plc (VACC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vaccitech plc (VACC) Enterprise Value vs. Peers

How is VACC’s Enterprise Value compared to its peers?

Vaccitech plc’s Enterprise Value is less than Molecular Partners AG (130.63M), greater than MediciNova, Inc. (-41974173594.00), greater than Anebulo Pharmaceuticals, Inc. (36.46M), less than Champions Oncology, Inc. (66.07M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Edgewise Therapeutics, Inc. (3.01B), less than Talaris Therapeutics, Inc. (50.00M), greater than Adicet Bio, Inc. (-13122100.00), less than Cullinan Oncology, Inc. (630.54M), greater than Vor Biopharma Inc. (34.31M), less than Tyra Biosciences, Inc. (703.47M), less than Third Harmonic Bio, Inc. (269.19M), less than C4 Therapeutics, Inc. (307.45M), less than Stoke Therapeutics, Inc. (457.69M), less than Revolution Medicines, Inc. (9.43B), less than Design Therapeutics, Inc. (290.40M), greater than Achilles Therapeutics plc (-38865958.00), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Magenta Therapeutics, Inc. (-114170976.00), greater than Graphite Bio, Inc. (-15007658.00), greater than CytomX Therapeutics, Inc. (39.67M), less than Instil Bio, Inc. (165.40M), greater than Spero Therapeutics, Inc. (-8426888.00), less than Assembly Biosciences, Inc. (68.59M),

Build a custom stock screener for Vaccitech plc (VACC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccitech plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaccitech plc (VACC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaccitech plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.